T2442 |
CPI203
|
202591-23-9
|
99.71%
|
|
CPI203 (CPI 203) is an effective BET bromodomain inhibitor (IC50: 37 nM for BRD4).
|
T5435 |
ARV-771
|
1949837-12-0
|
99.69%
|
|
ARV-771 is a potent BET degrader based on PROTAC technology with Kds of 34, 4.7, 8.3, 7.6, 9.6, and 7.6 nM for BRD2(1), BRD2(2), BRD3(1), BRD3(2), BRD4(1), and B...
|
T10616 |
BRM/BRG1 ATP Inhibitor-1
|
2270879-17-7
|
99.68%
|
|
BRM/BRG1 ATP Inhibitor-1 is an allosteric dual Brahma homolog (BRM)/SWI/SNF related matrix-associated actin-dependent regulator of chromatin subfamily A member 2...
|
T6026 |
CPI-203
|
1446144-04-2
|
99.66%
|
|
CPI-203 is an effective BET bromodomain inhibitor (IC50: 37 nM for BRD4).
|
T10641 |
C-82
|
1422253-37-9
|
99.66%
|
|
C-82 is a specific CBP/β-catenin antagonist. It inhibits the binding between β-catenin and CBP and increases the binding between β-catenin and p300.
|
T6255 |
Bromosporine
|
1619994-69-2
|
99.65%
|
|
Bromosporine is a broad spectrum inhibitor for bromodomains for BRD2/4/9 and CECR2 (IC50: 0.41/0.29/0.122/0.017 μM), respectively.
|
T8890 |
653-47 hydrochloride
|
1224567-46-7
|
99.65%
|
|
653-47 hydrochloride is a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15. It is also a ver...
|
T1993 |
J-147
|
1146963-51-0
|
99.61%
|
|
J-147 is an experimental drug with reported effects against both Alzheimer's disease and ageing in mouse models of accelerated aging. It is a curcumin derivative...
|
T11925 |
M‑89
|
2363165-42-6
|
99.58%
|
|
M-89, a highly potent and specific inhibitor of the menin-mixed lineage leukemia (Menin-MLL) protein-protein interaction, exhibits a Kd of 1.4 nM for menin bindi...
|
T5417 |
INCB-057643
|
1820889-23-3
|
99.58%
|
|
INCB057643 is a potent, selective and orally bioavailable BET inhibitor.
|
T60159 |
PBRM1-BD2-IN-5
|
2819989-61-0
|
99.55%
|
|
PBRM1-BD2-IN-5 is a potent inhibitor of the PBRM1 Bromodomain, demonstrating dissociation constant (Kd) values of 1.5 μM and 3.9 μM for PBRM1-BD2 and PBRM1-BD5, ...
|
T6113 |
ICG-001
|
780757-88-2
|
99.55%
|
|
ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CBP) with IC50 of 3 μM, but is not the related tr...
|
T5440 |
Dbet57
|
1883863-52-2
|
99.52%
|
|
dBET57 is heterobifunctional degrader of BRD4 based on the PROTAC technology, exhibits significant degradation of BRD4BD1 with a DC50/5h of 500 nM ,and inactive ...
|
T2436 |
GSK2801
|
1619994-68-1
|
99.5%
|
|
GSK2801 is an effective, specific and cell active acetyl-lysine competitive inhibitor of BAZ2A(Kd: 136 nM) and BAZ2B(Kd: 257 nM) bromodomains.
|
T60157 |
PBRM1-BD2-IN-8
|
2819989-75-6
|
99.48%
|
|
PBRM1-BD2-IN-8 (compound 34) is a potent PBRM1 Bromodomain inhibitor (PBRM1-BD2 Kd=4.4 μM, PBRM1-BD2 IC50=0.16 μM; PBRM1-BD5 Kd=25 μM). PBRM1-BD2-IN-8 shows anti...
|
T12551 |
PROTAC BRD4 ligand-1
|
2313230-51-0
|
99.48%
|
|
PROTAC BRD4 ligand-1 is a ligand for BRD4 for Protac GNE-987 and an inhibitor of BET.
|
T64117 |
BRD4-BD1-IN-2
|
2761321-26-8
|
99.47%
|
|
BRD4-BD1-IN-2 is a selective and potent BRD4-BD1 inhibitor with an IC50 value of 2.51 µM, which is 20-fold greater than the inhibitory activity against BRD4-BD2....
|
T0808 |
Diflunisal
|
22494-42-4
|
99.42%
|
|
Diflunisal (Dolobid) is a cyclooxygenase (COX) Inhibitor, used as an anti-inflammatory analgesic.
|
T10638 |
BY27
|
2247236-59-3
|
99.40%
|
|
BY27 is a potent and selective BET BD2 inhibitor (Ki: 3.1 nM) with anticancer activity, inhibits BD1/BD2 of BRD2, BRD3, BRD4 and BRDT, and suppresses tumor growt...
|
T5443 |
JQ-1 (carboxylic acid)
|
202592-23-2
|
99.39%
|
|
JQ-1 (carboxylic acid) is a cell-permeable BRD4 inhibitor with IC50s of 77 nM for BRD4(1) and 33 nM for BRD4(2)
|